Published on 30 Mar 2022 on Zacks via Yahoo Finance
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Athira Pharma, Inc. (ATHA) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Athira Pharma, Inc. is a member of our Medical group, which includes 1158 different companies and currently sits at #11 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Athira Pharma, Inc. is currently sporting a Zacks Rank of #2 (Buy).